Search clinical trials for: S-2367 Placebo

Total 55329 results

Shionogi

Completed

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet

Obesity

United States
Shionogi

Completed

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet

Obesity

United States
Shionogi

Completed

Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects (OLE)

Obesity

United States
Bayer

Terminated

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF) (COMPOSE 1)

Acute Heart Failure

Israel, Italy, Japan, Switzerland, United States, Austria, Germany, Thailand, Romania, Slovenia, Croatia, Serbia, Russian Federation, Finland, Sweden, Poland, Slovakia
Bayer

Terminated

Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667

Congestive Heart Failure

Spain, Germany, Italy, United States, Canada, Hungary, Israel, Estonia, Slovenia, Croatia, Serbia, Lithuania, Poland, Sweden, Russian Federation, Czech Republic, United Kingdom
Shionogi

Completed

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Obesity

United States
Bayer

Terminated

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF) (COMPOSE 2)

Acute Heart Failure

Belgium, France, Argentina, United States, Austria, Mexico, Germany, Philippines, Ireland
Bayer

Terminated

A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF) (COMPOSE EARLY)

Heart Failure | Heart Decompensation

Italy, United States, Germany, Spain, Japan, Canada, France, Hungary, Poland, South Africa, Korea, Republic of, Israel, Finland, United Kingdom, Ireland, Czech Republic
Kyowa Kirin Co., Ltd.

Terminated

Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Shionogi

Completed

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Chronic Cough

United States, United Kingdom, Japan, Ukraine, Poland, Czechia
Shionogi

Completed

A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis

Atopic Dermatitis

United States
Tokyo University
Shionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaborators

Unknown

Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer

Non-small- Cell Lung Cancer

Japan
Shionogi

Completed

A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Shionogi

Recruiting

A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants

Healthy Volunteers

United States
Shionogi

Recruiting

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection (SCORPIO-PEP)

SARS-CoV-2 Infection

Japan, United States
Shaare Zedek Medical Center

Unknown

Traumeel for Post-Tonsillectomy Pain

Post-Tonsillectomy

Israel
Shionogi

Active, not recruiting

Safety and Efficacy Study of S-309309 in Obese Adults

Obesity

United States
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers

Cardiovascular Diseases

Belgium
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Sarcoma | Lymphoma | Kidney Cancer | Leukemia | Neuroblastoma | Oral Complications

United States, Israel, Australia, Canada
Shaare Zedek Medical Center

Withdrawn

TRAUMEEL for Pain After Fracture of Neck of Femur

Pain | Fracture of Neck of Femur

Israel
University of Jena
German Federal Ministry of Education and Research

Completed

Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases

Ulcerative Colitis | Crohns Disease

Germany
HUYABIO International, LLC.

Recruiting

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Cancer | Colorectal Cancer | Pancreatic Cancer | Solid Tumor | Non Small Cell Lung Cancer | Cancer of Pancreas | Cancer of Colon

United States, Puerto Rico
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-7367 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
SolAeroMed Inc.

Not yet recruiting

Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.

Post Acute COVID-19 Syndrome | Long COVID | COVID-19 Respiratory Infection
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Terminated

Targeted Investigation of Microbiome Elimination (TIME-1)

Atopic Dermatitis

United States
Shionogi

Terminated

A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia (ITP)

United States
Lingfen Xu, MD

Completed

A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants (SBP)

Infant, Premature, Diseases
Virobay Inc.

Completed

Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)

Healthy

United States
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

Shigellosis | Dysentery

China
Celgene

Completed

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

Lymphoma | Advanced Solid Tumors

United States
Biocad

Completed

The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis (AURORA)

Seropositive RA

Russian Federation, Belarus
Shanghai Leadingtac Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase 1 Study of LT-002-158 Intended for the Treatment of Skind Disorder in Healthy Adult Volunteers

Atopic Dermatitis | Healthy Volunteer | Hidradenitis Suppurativa
Janssen Pharmaceutical K.K.

Completed

A Study of Ad26.COV2.S in Adults (COVID-19)

Healthy

Japan
Celgene
Stanford University

Terminated

VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas

Low Grade B Cell Lymphoma

United States
Sean Liu

Active, not recruiting

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

SARS-CoV-2

United States
University Hospital, Ghent

Completed

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery. (SeqB vs SIB)

Radiotherapy After Breast Conserving Surgery

Belgium
BlackThorn Therapeutics, Inc.

Completed

BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder

Major Depressive Disorder

United States
University of California, Davis
National Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Colorado... and other collaborators

Completed

Effects of SAMe in Patients With Alcoholic Liver Disease

Liver Disease, Alcoholic

United States
Medical University of Warsaw
National Science Centre, Poland

Recruiting

S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)

Primary Sclerosing Cholangitis (PSC)

Poland
Shaare Zedek Medical Center

Suspended

Traumeel S for Reduction of Post Operative Pain Following Arthroscopy

Post-operative Pain

Israel
Shiga University
University of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical... and other collaborators

Unknown

Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Japan
Shionogi

Completed

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Type 2 Diabetes Mellitus

United States
Shionogi

Completed

Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

Uroial Plus in the Management of Infections and Urinary Symptoms Associated With Ureteral Stents (USSIAL)

Urinary Tract Infections | Ureteral Stent-Related Symptom
Shionogi

Completed

Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)

Thrombocytopenia | Chronic Liver Disease
Shaare Zedek Medical Center

Terminated

TRAUMEEL for Pain After Total Knee/Hip Arthroplasty

Total Knee and Total Hip Arthroplasty

Israel
Universidad de La Frontera

Recruiting

Effectiveness of Photodynamic Therapy in the Disinfection of Root Canals in Patients With Apical Lesion (PDT)

Periapical Diseases | Endodontic Treatment

Chile
Universitätsklinikum Hamburg-Eppendorf
Ludwig-Maximilians - University of Munich; University Hospital Tuebingen; Philipps... and other collaborators

Withdrawn

COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

Covid19
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors

Neoplasms

United States
Boston Scientific Corporation

Completed

Boston Scientific Post Market S-ICD Registry (EFFORTLESS)

Tachycardia, Ventricular

United Kingdom, Denmark, Italy, New Zealand, Germany, France, Netherlands, Portugal, Czechia, Spain

Search clinical trials for: S-2367 Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations